EUROPE
GENESIS Pharma S.A.
Member: Gold
Since: 05.10.2006
Since: 05.10.2006
270, Kifissias Avenue, GR-152 32 Halandri, Athens, Greece
Corporate
Since its foundation in 1997, GENESIS Pharma has been a leading Greek biopharmaceutical company.
With its core business activity focusing on the sales, marketing and distribution of biopharmaceutical products, GENESIS Pharma has developed strategic alliances with 13 leading companies in the global biotechnology market, such as Amgen, Biogen Idec, Celgene, Cephalon, Pharmamar, Shire and Vifor.
The company has launched and marketed a unique portfolio of innovative biopharmaceutical products in Greece and Cyprus, principally within the specialty therapeutic areas of the Central Nervous System, Haematology, Nephrology and Oncology. Many of the company’s products treat rare chronic or life-threatening diseases and most of them address previously unmet or underserved clinical needs.
Today GENESIS Pharma employs 215 highly qualified full-time employees in Greece and Cyprus. Since its establishment, GENESIS Pharma has recognized and encouraged its employees' participation in its accomplishments and has strived to provide a positive working environment. The company was ranked among the top 10 companies in Greece for offering an excellent working environment for nine consecutive years (2003-2011) in the "Best Workplaces Hellas" competition and among the top 100 in Europe for the years 2005-2008 in the annual "Best Workplaces in Europe" competition.
The commitment and consistency of GENESIS Pharma to the principles of corporate responsibility have recently been sealed with a significant distinction. GENESIS Pharma is the first pharmaceutical company in Greece to be awarded for its CSR (Corporate Social Responsibility) performance for two consecutive years, in the National Corporate Responsibility Index.
In 2010, GENESIS Pharma ranked first in the list of "Greece's Most Productive Companies" in the sub-industry group "Pharmaceuticals / Cosmetics", according to Profiles International research study in Greece, with its consolidated turnover reaching EUR 223 million.
For further information, please visit: www.genesispharma.com.
With its core business activity focusing on the sales, marketing and distribution of biopharmaceutical products, GENESIS Pharma has developed strategic alliances with 13 leading companies in the global biotechnology market, such as Amgen, Biogen Idec, Celgene, Cephalon, Pharmamar, Shire and Vifor.
The company has launched and marketed a unique portfolio of innovative biopharmaceutical products in Greece and Cyprus, principally within the specialty therapeutic areas of the Central Nervous System, Haematology, Nephrology and Oncology. Many of the company’s products treat rare chronic or life-threatening diseases and most of them address previously unmet or underserved clinical needs.
Today GENESIS Pharma employs 215 highly qualified full-time employees in Greece and Cyprus. Since its establishment, GENESIS Pharma has recognized and encouraged its employees' participation in its accomplishments and has strived to provide a positive working environment. The company was ranked among the top 10 companies in Greece for offering an excellent working environment for nine consecutive years (2003-2011) in the "Best Workplaces Hellas" competition and among the top 100 in Europe for the years 2005-2008 in the annual "Best Workplaces in Europe" competition.
The commitment and consistency of GENESIS Pharma to the principles of corporate responsibility have recently been sealed with a significant distinction. GENESIS Pharma is the first pharmaceutical company in Greece to be awarded for its CSR (Corporate Social Responsibility) performance for two consecutive years, in the National Corporate Responsibility Index.
In 2010, GENESIS Pharma ranked first in the list of "Greece's Most Productive Companies" in the sub-industry group "Pharmaceuticals / Cosmetics", according to Profiles International research study in Greece, with its consolidated turnover reaching EUR 223 million.
For further information, please visit: www.genesispharma.com.
_.jpg)
